PACS Group, Inc.

Day range

$47.32 – $49.78

Open

$47.52

Prev close

$47.64

Volume

602.53K

Market cap

$7.54B

Shares out

158.27M

P/E

28.02

P/S

1.36

P/B

6.79

P/FCF

62.10

ROE

24.2%

ROA

4.8%

Debt/Equity

0.22

Div yield

0.00%

As of Oct 23, 2026

• Executive officer appointmentSep 21, 2026

  On September 21, 2026, the Company issued a press release announcing that Patrick J. Murphy will succeed Mr. Mitchell as Chief Legal Officer and Secretary, effective September 21, 2026.

• Cfo appointmentApr 27, 2026

  On April 24, 2026, the Board of Directors (the "Board") of PACS Group, Inc. (the "Company") appointed Carey Hendrickson to serve as the Company's Chief Financial Officer, effective as of April 27, 2026. Mr. Hendrickson, age 63, served as Chief Financial Officer of U.S. Physical Therapy, Inc. (NYSE: USPH)... From May 2014 to June 2018, he served as Senior Vice President and Chief Financial Officer... of Capital Senior Living Corporation (NYSE: CSU).

• Director appointmentMar 5, 2026

  On March 4, 2026, the Board of Directors (the "Board") of PACS Group, Inc. (the "Company"), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Patrick H. Conway, MD, MSc to the Board, effective immediately. Dr. Conway will serve as a Class III director for a term expiring at the Company's annual meeting of stockholders to be held in 2027.

• Annual meeting resultsDec 23, 2025

  On December 19, 2025, PACS Group, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). A total of 149,241,113 shares of the Company's common stock were represented online or by proxy at the Annual Meeting, representing approximately 95.29% of the Company's outstanding common stock as of the November 10, 2025 record date. Below are the voting results for the proposals considered and voted upon at the Annual Meeting.

• Covenant violationDec 1, 2025

  The Sixth Amendment, among other things, waived all defaults and events of default previously identified to the Administrative Agent and the lenders in the previously disclosed forbearance agreement, dated October 21, 2025. In addition, the Sixth Amendment provides that the financial covenant requiring the Company to maintain unrestricted cash and certain permitted investments of at least $100 million will only apply prior to the date on which the Company delivers financial statements and a related compliance certificate in respect of the fiscal quarter ending June 30, 2026.

Days to cover

4.9

Short interest

4.14M

Avg volume

838.04K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates
  neutralZacks Investment Research· Oct 21, 2026
• PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?
  neutralZacks Investment Research· Oct 16, 2026
• PACS Expands Florida Footprint With 32-Facility Acquisition
  positiveZacks Investment Research· Sep 8, 2026
• Here's Why Ensign Group Stock Remains a Buy for Investors
  positiveZacks Investment Research· Aug 27, 2026
• A PACS Group Insider Acquired 16,724 Shares for $500,000
  positiveThe Motley Fool· Dec 9, 2025